According to FDA labeling, the most frequent side effects include nausea (occurring in 12-29% of patients depending on dose), diarrhea (13-23%), vomiting (6-13%), constipation (6-11%), and abdominal pain (6-9%)
#GLP1 #MetabolicHealth #Innovation #MASLD #MASH #CKD #HFpEF Scott Isaacs, MD, FACP, FACEs Post GLP-1 medicines offer multi-faceted benefits: Reduce glucose and body weight Lower inflammation through weight loss and T cell activation Target multiple organs to reduce complications Show promise in treating cardio-renal issues and neurological disorders Exciting potential for broader applications
Zielsdorf has found is that a persons limbic system can become impaired, and they can get stuck in a trauma loop secondary to chronic illness
Geraadpleegd op 14 June 2023
1 Systemic involvement is typical and ACLE rashes often flare in parallel with other organ disease activity
If side effects are troublesome, your clinician may pause or step back